Delivery Order SPE2DB24D8003-SPE2DB25FJVCZ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,926.97 to Dakota Drug, Inc. for the supply of Lisdexamfetamine 20 mg capsules (100 count) with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents a pharmaceutical supply fulfillment under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The performance location is Anoka, Minnesota, where Dakota Drug...
- The Defense Logistics Agency awarded a delivery order valued at $2,011.46 to Dakota Drug, Inc., a small disadvantaged business located in Anoka, Minnesota, for the supply of Lisdexamfetamine 50 mg capsules (100-count units). This firm fixed price delivery order was issued on August 21, 2025, with an ultimate completion date of August 22, 2025, and carries no set-aside designation. The award is issued under Dakota Drug's larger Indefinite Delivery Contract (SPE2DB24D8001) with DLA Troop Support...
- This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,042.84, is for the delivery of 4,567,372,214 lisdexamfetamine 40 mg capsules, to be completed by February 26, 2025. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $1,229.69 firm fixed price delivery order is for the supply of 100 units of the medication lisdexamfetamine 60 mg capsules. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the DLA Troop Support Medical's ECAT Generation V Program, which allows the company to provide...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The award, with a contract number of SPE2DB24D8002|SPE2DB25FJNDD, is for the delivery of 4,567,235 units of 50 mg lisdexamfetamine capsules. The contract has a firm fixed-price delivery order type with a ceiling value of $1,350.58 and a completion date of February 12, 2025. Dakota Drug, Inc. is also the holder of a significant single-award Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of lisdexamfetamine 50 mg capsules, a pharmaceutical product. The contract has a ceiling value of $2,326.86 and a completion date of December 18, 2024. This contract is not set aside for any special designation. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, identified as...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,000.64, is for the delivery of 4566862011 - LISDEXAMFETAMINE 40 MG CAPSULE 100S to support U.S. Armed Forces medical operations. The contract has a firm fixed price pricing type and an ultimate completion date of January 8, 2025. It is not a set-aside contract. Dakota Drug, Inc. is a key supplier for the DLA Troop...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, valued at $1,161.78, is for the delivery of VYVANSE 40 MG CAPSULE 100S. The contract has an ultimate completion date of July 18, 2025. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Lisdexamfetamine 40 mg capsules (100-count units) under a firm fixed-price contract with a ceiling value of $1,137.22. This non-set-aside delivery order is scheduled for ultimate completion on August 19, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $4,783.81 firm fixed-price contract is for the delivery of VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product. The contract has a period of performance through February 24, 2025. Dakota Drug, Inc. is a key supplier to the DLA, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) as part of the DLA Troop Support Medical's ECAT...
- SPE2DB24D8003Indefinite Delivery Contract
- SPE2DB24D8003-SPE2DB25FJVCZDelivery Order
The Defense Logistics Agency awarded Dakota Drug, Inc. a delivery order valued at $1,578.15 for 100 capsules of lisdexamfetamine 10 mg on September 2, 2025, with completion scheduled for September 3, 2025. This firm fixed-price delivery order is issued without set-aside designation and represents a direct purchase under the company's existing indefinite delivery contract with DLA Troop Support Medical. The work will be performed in Anoka, Minnesota, where Dakota Drug maintains its operations as a self-certified small disadvantaged business specializing in pharmaceutical and medical supply distribution to federal healthcare facilities. Dakota Drug, Inc. operates under a significant single-award indefinite delivery contract (SPE2DB24D8001) valued at $999,999,999.00 with DLA Troop Support Medical's ECAT Generation V Program, which extends through December 31, 2025. This broader contract vehicle, originating from solicitation SPE2DH-21-R-0002, enables the company to provide comprehensive pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The current delivery order for lisdexamfetamine is representative of Dakota Drug's critical role in the military medical supply chain, fulfilling ongoing demand for pharmaceutical medications across defense healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 9/2/25 |